Bortezomib-thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma

Br J Haematol. 2015 Feb;168(4):605-6. doi: 10.1111/bjh.13128. Epub 2014 Sep 19.
No abstract available

Keywords: autologous stem cell transplantation; bortezomib; induction therapy; multiple myeloma.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Multiple Myeloma / drug therapy*